Entering text into the input field will update the search result below

Alnylam Pharmaceuticals, Inc. (ALNY) CEO John Maraganore On Q1 2020 Results - Earnings Call Transcript

May 06, 2020 7:22 PM ETAlnylam Pharmaceuticals, Inc. (ALNY)
SA Transcripts profile picture
SA Transcripts

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2020 Earnings Conference Call May 5, 2020 10:00 AM ET

Company Participants

Christine Lindenboom - VP, IR and Corporate Communications

John Maraganore - CEO

Barry Greene - President

Akshay Vaishnaw - President of R&D

Jeff Poulton - Chief Financial Officer

Yvonne Greenstreet - Chief Operating Officer

Conference Call Participants

David Lebowitz - Morgan Stanley

Tazeen Ahmad - Bank of America

Paul Matteis - Stifel

Anupam Rama - JP Morgan

Ritu Baral - Cowen

Salveen Richter - Goldman Sachs

Ted Tenthoff - Piper Sandler

Mani Foroohar - SVB Leerink

Alan Carr - Needham


Ladies and gentlemen, thank you for standing-by. Welcome to the Alnylam Pharmaceuticals First Quarter 2020 Conference Call. There will be a question-and-answer session to follow. Please be advised that this call is being taped at the company’s request.

I would now like to turn the call over to the company.

Christine Lindenboom

Good morning. I’m Christine Lindenboom, Senior Vice President of Investor Relations and Corporate Communications at Alnylam. With me today on the phone are John Maraganore, Chief Executive Officer; Barry Greene, President; Akshay Vaishnaw, President of R&D, Jeff Poulton, Chief Financial Officer; and Yvonne Greenstreet, Chief Operating Officer.

For those of you participating via conference call, the accompanying slides can be accessed by going to the event section of the Investor page of our website at www.alnylam.com/event.

During today’s call, as outlined in Slide 2, John will provide some introductory remarks and general context. Barry will provide an update on our commercial and medical affairs progress. Akshay will review recent clinical and pre-clinical updates, Jeff will review our financials and Yvonne will provide a brief summary of upcoming milestones before opening the call for your questions.

I would like to remind you that this call will contain remarks concerning Alnylam’s future

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.